CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

BioMarin Pharmaceutical Non-GAAP EPS of $1.20 beats by $0.25, revenue of $989.7M beats by $56.94M

EarningsPositive
AI Analysis

Summary

BioMarin Pharmaceutical reported Q2 2026 non-GAAP EPS of $1.20, beating estimates by $0.25, and revenue of $989.7M, exceeding expectations by $56.94M.

Financial Highlights

Revenue

$989.7M

EPS

$1.20

Importance:5/10
Sentiment:
0.70
earningsbeatfinancial_results
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 6, 2026 8:29 PM

Read Original